RESEARCH MONOGRAPH · KDC-MN-128

Thymulin

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

60/100

The zinc-dependent thymic nonapeptide is the most chemically defined of the thymic family, and the zinc dependence matters

Thymulin is the one in the thymic peptide family thats actually a defined molecule with crystallographic and NMR characterization. Nonapeptide (pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) that needs a zinc ion to fold into its bioactive conformation. Without zinc its inactive. With zinc it modulates T-cell differentiation and CD4/CD8 balance. Bach's group at Pasteur in the 1970s and 80s did most of the foundational work.

What makes Thymulin interesting as a research tool is the zinc piece. Aged populations are frequently zinc-deficient, and Thymulin activity drops with age partly because endogenous zinc availability drops. So you have a peptide whose activity is gated by a cofactor thats clinically variable. Thats a useful model for thinking about how nutritional status modulates peptide signaling more generally.

The mechanism is reasonably well-mapped. Effects on thymocyte maturation, modulation of IL-2 receptor expression, dampening of some inflammatory responses. There's also been work on Thymulin in nociception models showing reductions in inflammatory pain that ran through TNF and IL-1 pathways, which was a surprise direction for what started as a T-cell paper.

What we like: defined sequence means reproducibility. Zinc dependence is a feature, not a bug, for studying co-factor-gated signaling. The pain modulation literature opens up a separate research angle from the immune one.

What we dont like: clinical translation has been thin. Most of the human data is from small Italian and French trials in the 90s with mixed endpoints. Production stopped being a commercial priority decades ago, so what's on the research market is mostly synthetic peptide reproducing the published sequence rather than something derived from biological material.

Sourcing: synthetic, short, HPLC characterization is straightforward. But check that vendors are providing the pGlu-modified N-terminus correctly; thats the kind of detail thats easy to skip and ruins your reproducibility.

If you're interested in the broader thymic-peptide literature, this is probably the cleanest entry point because at least you know what molecule you're working with. The Khavinson preparations are murkier.

Evidence: 50
Mechanism: 65
Reliability: 60
Safety: 78
Sourcing: 65
Value: 55
Signal: 55
Staying power: 55

Plain-language summary Intrigue 50 / 100

Thymulin is a 9-amino-acid zinc-dependent thymic hormone that regulates T-cell development. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Zinc-dependent thymic nonapeptide

A zinc-dependent endogenous thymic nonapeptide secreted by thymic epithelial cells with T-cell maturation activity.

Abstract

Thymulin (Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn; molecular weight 857) is a nonapeptide originally isolated by Bach and Goldstein groups in the 1970s. The peptide is endogenously secreted by thymic epithelial cells and requires bound zinc for biological activity. Pharmacology includes promotion of T-cell differentiation, modulation of cytokine balance, and effects on autoimmune and inflammatory processes. The compound has been studied in chronic infections, autoimmune diseases, and cancer immunotherapy adjunct applications, with limited Phase 2 evidence. Available as research peptide. Reported research dose ranges in the literature are typically 100 to 1000 micrograms.

Mechanism of action

Zinc-dependent T-cell maturation factor; modulates Th1/Th2 cytokine balance.

Reported research dose ranges

Reported research dose ranges in the literature are typically 100 to 1000 micrograms.

References

Bach JF. Thymic hormones: from bench to bedside. J Immunol Methods 2008.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-128

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Thymulin

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs